NCT01796483View on ClinicalTrials.gov

EEG and Pharmacological Exploration of Executive Dysfunctions Induced by STN-DBS in PD

NACompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2016

Conditions
Parkinson Disease
Interventions
DEVICE

Clonidine (Catapressan)

Clonidine (Catapressan) : Oral administration - Single dose (150 µg) - 90 minutes before EEG

DEVICE

Placebo 90 minutes before EEG

Placebo : Oral administration - Single dose (lactose) - 90 minutes before EEG

Trial Locations (1)

69677

Hospices Civils de Lyon Hôpital Pierre Wertheimer, Bron

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT01796483 - EEG and Pharmacological Exploration of Executive Dysfunctions Induced by STN-DBS in PD | Biotech Hunter | Biotech Hunter